Bone Morphogenetic Protein 5 (BMP5) (Middle Region) Peptid
BMP5
Reaktivität: Human
Wirt: Synthetic
WB
Produktnummer ABIN5518116
Kurzübersicht für Bone Morphogenetic Protein 5 (BMP5) (Middle Region) Peptid (ABIN5518116)
Target
BMP5
(Bone Morphogenetic Protein 5 (BMP5))
Spezies
Human
Quelle
Synthetic
Applikation
Western Blotting (WB)
-
-
Protein Region
- Middle Region
-
Sequenz
- QGPQSKQPFM VAFFKASEVL LRSVRAANKR KNQNRNKSSS HQDSSRMSSV
-
-
Bone Morphogenetic Protein 5 (BMP5) (AA 317-454) peptide
BMP5 Reaktivität: Human Wirt: Escherichia coli (E. coli) SDS
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- BMP5 (Bone Morphogenetic Protein 5 (BMP5))
-
Hintergrund
-
This gene encodes a member of the bone morphogenetic protein family which is part of the transforming growth factor-beta superfamily. The superfamily includes large families of growth and differentiation factors. Bone morphogenetic proteins were originally identified by an ability of demineralized bone extract to induce endochondral osteogenesis in vivo in an extraskeletal site. These proteins are synthesized as prepropeptides, cleaved, and then processed into dimeric proteins. This protein may act as an important signaling molecule within the trabecular meshwork and optic nerve head, and may play a potential role in glaucoma pathogenesis. This gene is differentially regulated during the formation of various tumors.
Protein Size: 167 -
Gen-ID
- 653
-
NCBI Accession
- NM_021073, NP_066551
-
UniProt
- P22003
Target
-
Sie sind hier:
